[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339147-105":59,"doc-detail-339147-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bayesian-and-deep-learning-models-applied-to-the-early-detection-of-ovarian-cancer-using-multiple-longitudinal-biomarkers","Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers","","Background: Ovarian cancer is the most lethal gynecologic cancer, and CA125 remains the best biomarker yet underperforms as a screening test in the general population. Recent studies suggest additional biomarkers could improve early detection when modeled longitudinally. Methods: Data included 180 controls and 44 cases with serum samples from the UKCTOCS multimodal arm. Models used Bayesian change-point detection and recurrent neural networks. Results: CA125–HE4 achieved higher performance than CA125 alone one year before diagnosis, while outperforming depended on the time horizon. Conclusions: Longitudinal multivariable combinations of biomarkers can improve ovarian cancer detection rates beyond CA125 alone.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bayesian-and-deep-learning-models-applied-to-the-early-detection-of-ovarian-cancer-using-multiple-longitudinal-biomarkers/339147/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bayesian-and-deep-learning-models-applied-to-the-early-detection-of-ovarian-cancer-using-multiple-longitudinal-biomarkers/339147.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is CA125 insufficient for population ovarian cancer screening?","Question",{"text":112,"@type":113},"CA125 is the best-performing ovarian cancer biomarker, but it is still not effective as a screening test in the general population. The study motivates improved performance using additional biomarkers and longitudinal modeling.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and modeling methods were used in the study?",{"text":117,"@type":113},"The dataset included 180 controls and 44 cases with serum samples from the UKCTOCS multimodal arm. The models were based on Bayesian change-point detection and recurrent neural networks.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the CA125–HE4 model compare with CA125 alone?",{"text":121,"@type":113},"Both methodologies showed significantly higher performance for the CA125–HE4 model versus CA125 alone, with high AUC and sensitivity values. The advantage was also observed one year before diagnosis, while the relative ranking changed at two years before diagnosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339147,1790793039,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","DOI: 10. 1002/cam4 .7163  \nRESEAR CH ARTICLE  \nBayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers  \nLuis Abrego1,2 | Alexey Zaikin1,2 | Ines P. Marino3 | Mikhail I. Krivonosov4,5 | Ian Jacobs1 | Usha Menon6 | Aleksandra Gentry-Maharaj1,6 | Oleg Blyuss1,7,8   \n1Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK 2Department of Mathematics, University College London, London, UK  \n3Department of Biology and Geology, Physics and Inorganic Chemistry, Universidad Rey Juan Carlos, Madrid, Spain  \n4Research Center for Trusted Artificial Intelligence, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia  \n5Institute of Biogerontology, Lobachevsky State University, Nizhny Novgorod, Russia 6MRC Clinical Trials Unit, University College London, London, UK  \n7Wolfson Institute of Population Health, Queen Mary University of London, London, UK  \n8Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia  \nCorrespondence  \nOleg Blyuss, Centre for Cancer Screening, Prevention and Early Detection, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. [Email:](Email: o.blyuss@qmul.ac.uk)[ o.blyuss@qmul.ac.uk](Email: o.blyuss@qmul.ac.uk)  \nFunding information  \nCancer Research UK and  \nEPSRC, Grant/Award Number: EDDCPJT/100022  \nAbstract  \nBackground: Ovarian cancer is the most lethal of all gynecological cancers. Cancer Antigen 125 (CA125) is the best-performing ovarian cancer biomarker which however is still not effective as a screening test in the general population. Recent literature reports additional biomarkers with the potential to improve on CA125 for early detection when using longitudinal multimarker models. Methods: Our data comprised 180 controls and 44 cases with serum samples sourced from the multimodal arm of UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Our models were based on Bayesian change-point detection and recurrent neural networks.  \nResults: We obtained a significantly higher performance for CA125–HE4 model using both methodologies (AUC 0.971, sensitivity 96.7% and AUC 0.987, sensitivity 96.7%) with respect to CA125 (AUC 0.949, sensitivity 90.8% and AUC 0.953, sensitivity 92.1%) for Bayesian change-point model (BCP) and recurrent neural networks (RNN) approaches, respectively. One year before diagnosis, the CA125– HE4 model also ranked as the best, whereas at 2 years before diagnosis no multimarker model outperformed CA125 .  \nConclusions: Our study identified and tested different combination of biomarkers using longitudinal multivariable models that outperformed CA125 alone. We  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7163 .  \n[https://doi.org/10.1002/cam4.7163](https://doi.org/10.1002/cam4.7163)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 14  \nshowed the potential of multivariable models and candidate biomarkers to increase the detection rate of ovarian cancer.  \nKEYWORDS  \nCA125, change-point detection, longitudinal biomarkers, ovarian cancer, recurrent neural networks  \n1 | INTRODUCTION  \nOvarian cancer is the most lethalofall gynecological cancers. When detected at early stage, the survival is much more encouraging (5-year survival of >93% for Stage I disease) than when diagnosed at an advanced stage (5-year survival of 13% for Stage IV) .1 Despite the extensive efforts to improve treatment over the last 20 years, although there have been modest improvements in survival","cbCaicFd5GHGw63D","https://ap.wps.com/l/cbCaicFd5GHGw63D","pdf",1214510,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and survival by stage\n## Limitations of CA125 cutoff screening\n## Longitudinal CA125 and algorithmic screening approaches\n## ROCA and HE4 as a second marker\n## Need for multivarker longitudinal modeling\n## Prior work and study extension","[{\"question\":\"Why is CA125 insufficient for population ovarian cancer screening?\",\"answer\":\"CA125 is the best-performing ovarian cancer biomarker, but it is still not effective as a screening test in the general population. The study motivates improved performance using additional biomarkers and longitudinal modeling.\"},{\"question\":\"What data and modeling methods were used in the study?\",\"answer\":\"The dataset included 180 controls and 44 cases with serum samples from the UKCTOCS multimodal arm. The models were based on Bayesian change-point detection and recurrent neural networks.\"},{\"question\":\"How did the CA125–HE4 model compare with CA125 alone?\",\"answer\":\"Both methodologies showed significantly higher performance for the CA125–HE4 model versus CA125 alone, with high AUC and sensitivity values. The advantage was also observed one year before diagnosis, while the relative ranking changed at two years before diagnosis.\"}]","Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers | PDF",1790028225,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8054e73c4fdc62343e6c8e6a9e6fbbc.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/285325a3da86b46cb5858e886b40fa88.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7b4779178096d0bb10cd2bfb48f9127.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ebf71d99c3ddd5d78ff9a6fa90ccd9a.webp",980,1287]